Table 4.
Cell expansion medium composition (blank entries indicate the information was not available to the authors). The last column represents additional supplements that were added to the existing expansion medium to formulate the medium used for 3D culture. Cell passage numbers are indicated in Table 1.
Product | Base Medium | Serum | Antibiotics | Growth Factors | Ascorbate | Other Additives |
3D Culture |
---|---|---|---|---|---|---|---|
Biocart™II | Autologous serum | FGF-2 variant (10 ng/mL) |
|||||
Bioseed-C | Autologous serum | ||||||
Cartipatch® | DMEM/Ham’s F-12 (1:1) |
10% autologous serum |
Gentamycin fungizone (discontinued after P1 |
50 μg/mL | |||
Chondrosphere® | DMEM/Ham’s F-12 (1:1) |
Autologous serum | None | None | |||
Hyalograft® C | Ham’s F-12 | 10% FCS | Penicillin streptomycin |
TGF-B1 (1ng/mL), FGF-2 (5ng/mL), EGF (1ng/mL) |
1 ng/mL insulin 1% L-glutamine |
+ 50 mg/mL ascorbic acid |
|
MACI | DMEM | 9% FBS | Gentamycin | ||||
NeoCart® | |||||||
NOVOCART® 3D | Allogeneic serum | None | |||||
RevaFlex™ | HL-1 or similar | 10% serum to serum-free |
Yes | 50 μg/mL |